Department of Radiation Oncolcgy,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Science,Peking Union Medical College,Beijing 100021,China
Abstract：Objective To evaluate the risk of locoregional recurrence (LRR) and the influencing factors for long-term survival in patients with epithelial-myoepithelial carcinoma (EMCa).Methods A retrospective analysis was performed for 18 EMCa patients, who received initial therapy or initial adjuvant therapy in our hospital from 1999 to 2015, to investigate their survival. Among these patients, 8(44%) underwent surgery alone, 9(50%) received adjuvant radiotherapy, and 1(6%) received radical concurrent chemoradiotherapy. Locoregional recurrence-free survival (LRFS) and overall survival (OS) rates were compared between these groups. The Kaplan-Meier mtthod was used to calculated survival rates and log-rank test was used to compare the LRFS.Results With a median follow-up time of 46 months, 5 patients developed LRR, and the 5-year LRFS and OS rates were 69% and 93%, respectively. The patients treated with radiotherapy had a significantly higher 5-year LRRFS rate than those not treated with radiotherapy (71% vs. 57%, P=0.569). Conclusions LRR is the main failure mode of EMCa treatment, and further improving local control is the key to improved survival.
Zhang Jianghu,Huang Xiaodong,Gao Li et al. A retrospective study of the treatment for epithelial-myoepithelial carcinoma[J]. Chinese Journal of Radiation Oncology, 2017, 26(5): 513-516.
[1] Donath K,Seifert G,Schmitz R.Diagnosis and ultrastructure of the tubular carcinoma of salivary gland ducts. Epithelial-myoepithelial carcinoma of the intercalated ducts[J].Virchows Arch A Pathol Pathol Anat,1972,356(1):16-31. [2] Tsuneyama K,Hoso M,Kono N,et al. An unusual case of epithelial-myoepithelial carcinoma of the liver[J].Am J Surg Pathol,1999,23(2):349-353. [3] 刘勇,桑新亭,高维生等.肝脏原发上皮-肌上皮癌首例报告[J].中华外科杂志,2006,44(21):1477-1479.DOI:10.3760/j:issn:0529-5815.2006.21.012. Liu Y,Sang XT,Gao WS,et al. The first case of primary epithelial-myoepithelial carcinoma in the liver[J].Chin J Surg,2006,44(21):1477-1479. [4] Brocheriou C,Auriol M,de Roquancourt A,et al. Epithelial-myoepithelial carcinoma of the salivary glands. Study of 15 cases and review of the literature[J].Ann Pathol,1991,11(2):316-325. [5] Seethala RR,Barnes EL,Hunt JL.Epithelial-myoepithelial carcinoma:a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract[J].Am J Surg Pathol,2007,31(1):44-57. [6] Dimitrijevic MV,Tomanovic NR,Jesic SD,et al. Epithelial-myoepithelial carcinoma—review of clinicopathological and immunohistochemical features[J].Arch Iran Med,2015,18(2):218-222.DOI:15184/AIM.005. [7] Vazquez A,Patel TD,D′Aguillo CM,et al. Epithelial-Myoepithelial carcinoma of the salivary glands:an analysis of 246 cases[J].Otolaryngol Head Neck Surg,2015,153(4):569-574.DOI:10.1177/0194599815594788. [8] Seethala RR,Richmond JA,Hoschar AP,et al. New variants of epithelial-myoepithelial carcinoma:oncocytic-sebaceous and apocrine[J].Arch Pathol Lab Med,2009,133(6):950-959.DOI:10.1043/1543-2165-133.6.950.
2017, Vol. 26 
